Velasco-Torrijos T - Search Results

1

Click Pt(IV)-Carbohydrates Pro-Drugs for Treatment of Osteosarcoma.

Moynihan E, Bassi G, Ruffini A, Panseri S, Montesi M, Velasco-Torrijos T, Montagner D. Moynihan E, et al. Among authors: velasco torrijos t. Front Chem. 2021 Dec 7;9:795997. doi: 10.3389/fchem.2021.795997. eCollection 2021. Front Chem. 2021. PMID: 34950638 Free PMC article.

2

Development of Novel Pt(IV)-Carbohydrate Derivatives as Targeted Anticancer Agents against Osteosarcoma.

Moynihan E, Panseri S, Bassi G, Rossi A, Campodoni E, Dempsey E, Montesi M, Velasco-Torrijos T, Montagner D. Moynihan E, et al. Among authors: velasco torrijos t. Int J Mol Sci. 2023 Mar 23;24(7):6028. doi: 10.3390/ijms24076028. Int J Mol Sci. 2023. PMID: 37047001 Free PMC article.

3

Novel design of dual-action Pt(IV) anticancer pro-drugs based on cisplatin and derivatives of the tyrosine kinase inhibitors imatinib and nilotinib.

Beirne DF, Farkaš B, Donati C, Gandin V, Rozas I, Velasco-Torrijos T, Montagner D. Beirne DF, et al. Among authors: velasco torrijos t. Dalton Trans. 2023 Oct 10;52(39):14110-14122. doi: 10.1039/d3dt02030d. Dalton Trans. 2023. PMID: 37747105

4

Editorial: Glyco-Tools to Crack Unsolved Biomedical Needs.

Marcelo F, Nativi C, Russo L, Silipo A, Velasco-Torrijos T. Marcelo F, et al. Among authors: velasco torrijos t. Front Chem. 2021 Nov 18;9:789839. doi: 10.3389/fchem.2021.789839. eCollection 2021. Front Chem. 2021. PMID: 34869237 Free PMC article. No abstract available.

5

Targeting adhesion in fungal pathogen Candida albicans.

Martin H, Kavanagh K, Velasco-Torrijos T. Martin H, et al. Future Med Chem. 2021 Feb;13(3):313-334. doi: 10.4155/fmc-2020-0052. Epub 2020 Jun 22. Future Med Chem. 2021. PMID: 32564615 Free article. Review.

6

Multivalent Presentations of Glycomimetic Inhibitor of the Adhesion of Fungal Pathogen Candida albicans to Human Buccal Epithelial Cells.

Martin H, Goyard D, Margalit A, Doherty K, Renaudet O, Kavanagh K, Velasco-Torrijos T. Martin H, et al. Among authors: velasco torrijos t. Bioconjug Chem. 2021 May 19;32(5):971-982. doi: 10.1021/acs.bioconjchem.1c00115. Epub 2021 Apr 22. Bioconjug Chem. 2021. PMID: 33887134 Free PMC article.

7

Synthesis of bivalent lactosides based on terephthalamide, N,N'-diglucosylterephthalamide, and glycophane scaffolds and assessment of their inhibitory capacity on medically relevant lectins.

Leyden R, Velasco-Torrijos T, André S, Gouin S, Gabius HJ, Murphy PV. Leyden R, et al. J Org Chem. 2009 Dec 4;74(23):9010-26. doi: 10.1021/jo901667r. J Org Chem. 2009. PMID: 19899775

8

Scaffold diversity for enhanced activity of glycosylated inhibitors of fungal adhesion.

Martin H, Somers T, Dwyer M, Robson R, Pfeffer FM, Bjornsson R, Krämer T, Kavanagh K, Velasco-Torrijos T. Martin H, et al. Among authors: velasco torrijos t. RSC Med Chem. 2020 Aug 17;11(12):1386-1401. doi: 10.1039/d0md00224k. eCollection 2020 Dec 17. RSC Med Chem. 2020. PMID: 34095846 Free PMC article.

9

Polymorphism in Commercial Sources of Fusidic Acid: A Comparative Study of the In Vitro Release Characteristics of Forms I and III from a Marketed Pharmaceutical Cream.

Byrne J, Reinhardt R, Velasco-Torrijos T. Byrne J, et al. J Anal Methods Chem. 2017;2017:3493096. doi: 10.1155/2017/3493096. Epub 2017 Sep 17. J Anal Methods Chem. 2017. PMID: 29075549 Free PMC article.

10

Inhibition of adherence of the yeast Candida albicans to buccal epithelial cells by synthetic aromatic glycoconjugates.

Martin H, Govern MM, Abbey L, Gilroy A, Mullins S, Howell S, Kavanagh K, Velasco-Torrijos T. Martin H, et al. Eur J Med Chem. 2018 Dec 5;160:82-93. doi: 10.1016/j.ejmech.2018.10.011. Epub 2018 Oct 9. Eur J Med Chem. 2018. PMID: 30321803

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page